At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the foundation of successful drug manufacturing lies in the precision and quality of the chemical building blocks used. Our product, 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine (CAS 941685-26-3), is a prime example of such a critical component, particularly for the production of Ruxolitinib.

This advanced pyrrolo[2,3-d]pyrimidine derivative is meticulously synthesized to achieve high purity, ensuring its suitability for demanding pharmaceutical applications. The molecular formula C12H18ClN3OSi and molecular weight of 283.833 are precisely controlled to guarantee its role as an effective Ruxolitinib intermediate. By providing this compound with a purity exceeding 99%, we empower manufacturers to produce Ruxolitinib with confidence, knowing they are using a reliable and high-quality starting material.

The synthesis of Active Pharmaceutical Ingredients (APIs) like Ruxolitinib involves complex multi-step processes. The quality of each intermediate directly impacts the overall yield, purity, and cost-effectiveness of the final API. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting our clients by delivering intermediates that meet the highest industry standards. This commitment extends to providing comprehensive documentation, including Material Safety Data Sheets (MSDS) and Certificates of Analysis (CoA).

Our expertise in fine chemical synthesis allows us to not only supply standard products but also to engage in custom synthesis projects. This flexibility ensures that we can support the diverse needs of the pharmaceutical industry, from early-stage drug discovery to large-scale commercial manufacturing. The consistent demand for reliable chemical building blocks for API synthesis underscores our dedication to being a leading provider in this sector.

NINGBO INNO PHARMCHEM CO.,LTD. aims to be a trusted partner for all your pharmaceutical intermediate needs. We believe that by focusing on product quality, efficient supply chain management, and dedicated customer service, we can contribute significantly to the advancement of critical therapies such as Ruxolitinib. Choose us for your sourcing needs and experience the precision that comes with working with a dedicated chemical synthesis expert.